Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

Federal funding opportunity PA-24-253 from National Institutes of Health (Department of Health and Human Services).

Apply on Grants.gov →Application closes July 17, 2027

Program funding history

Synopsis

Who can apply

• For profit organizations other than small businesses
• Public and State controlled institutions of higher education
• Native American tribal organizations (other than Federally recognized tribal governments)
• Independent school districts
• Native American tribal governments (Federally recognized)
• Special district governments
• Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
• Public housing authorities/Indian housing authorities
• Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
• Private institutions of higher education
• State governments
• Others (see text field entitled "Additional Information on Eligibility" for clarification)
• County governments
• Small businesses
• City or township governments

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

How to apply

Similar grants

• Change of Recipient Organization (Type 7 Parent Clinical Trial Optional)
  PA-24-254 · National Institutes of Health · closes July 12, 2027
• NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Independent Clinical Trial Not Allowed)
  PAR-24-209 · National Institutes of Health · closes July 12, 2027
• NHLBI Career Transition Award for Intramural Postdoctoral Fellows and Research Trainees (K22 Clinical Trial Required)
  PAR-24-211 · National Institutes of Health · closes July 12, 2027
• Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
  RFA-TR-25-002 · National Institutes of Health · closes July 2, 2027
• Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional)
  PAR-25-101 · National Institutes of Health · closes August 11, 2027
• Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
  RFA-DC-26-001 · National Institutes of Health · closes June 17, 2027